Orbimed Advisors LLC Magenta Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	BUY	$4.43 - $8.33 $1.59 Million - $2.98 Million	358,000 Added 18.91%	2,250,953 $9.97 Million
Q3 2021 Nov 15, 2021	SELL	$6.07 - $9.89 $854,692 - $1.39 Million	-140,806 Reduced 6.92%	1,892,953 $13.8 Million
Q2 2021 Aug 16, 2021	BUY	$9.76 - $14.15 $10.6 Million - $15.3 Million	1,084,711 Added 114.29%	2,033,759 $19.9 Million
Q1 2021 May 17, 2021	BUY	$7.66 - $13.38 $7.27 Million - $12.7 Million	949,048 New	949,048 $11.2 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.